Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 18 de 18
Filter
1.
Dig Liver Dis ; 51(11): 1574-1579, 2019 11.
Article in English | MEDLINE | ID: mdl-31147212

ABSTRACT

BACKGROUND: No study has compared the performance of light microscopy (LM) and whole slide imaging (WSI) for endoscopic ultrasound (EUS) histological acquired tissue samples from pancreatic solid lesions (PSLs). We evaluated the concordance between LM and WSI and the inter- and intra-observer agreements among pathologists on PSLs EUS acquired samples. METHODS: LM and WSI from 60 patients with PSLs were evaluated by five expert pathologists to define: diagnostic classification, presence of a core, number and percentage of lesional cells. Washout period between evaluations was 3 months. Time of the procedures was also assessed. RESULTS: Forty-eight cell-block and 12 biopsy samples were evaluated. A high concordance between LM and WSI was found. Inter- and intra-observer agreements for diagnostic classification were substantial and complete, respectively. For all the other parameters, the inter-observer agreement was usually higher for LM. For the intra-observer, a substantial agreement was reached regarding the presence of tissue core and the number and the percentage of malignant cells. Median time for performing LM was significantly shorter than for WSI (p < 0.0001). CONCLUSIONS: LM and WSI of cell-block and biopsy samples acquired by EUS in PSLs were highly concordant, with a substantial inter-observer and a complete intra-observer agreements regarding diagnostic classification.


Subject(s)
Diagnostic Imaging/methods , Microscopy/methods , Pancreas/pathology , Pathology, Clinical/methods , Diagnostic Imaging/instrumentation , Endosonography , Humans , Image Interpretation, Computer-Assisted/methods , Microscopy/instrumentation , Observer Variation , Pathology, Clinical/instrumentation , Retrospective Studies
2.
Int J Surg Pathol ; 25(1): 83-86, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27435300

ABSTRACT

A case of endobronchial pagetoid spread of a breast carcinoma metastatic to the lung is described. A 73-year-old woman underwent wedge lung resection after the cytological diagnosis of lung metastasis from ductal invasive breast carcinoma. The breast carcinoma had been surgically removed 6 years previously; at the time of diagnosis it was a T1N0, grade 3 invasive ductal carcinoma, with HER-2 amplification. The lung metastasis measured 1,9 cm and showed the same histology and biological profile of the primary tumor. In addition, numerous neoplastic cells, with large cytoplasm and atypical nuclei, appear to spread along the mucosa of the bronchi adjacent to the metastatic lesion as well as that of the main lobar bronchus, intermingled with the columnar ciliated cells. The neoplastic elements were negative for TTF-1 and strongly HER-2 positive; these features appeared consistent with endobronchial pagetoid spread by the metastatic breast carcinomatous cells.


Subject(s)
Breast Neoplasms/pathology , Carcinoma, Ductal, Breast/secondary , Lung Neoplasms/secondary , Neoplasm Invasiveness/pathology , Aged , Biomarkers, Tumor/analysis , Bronchi/pathology , Female , Humans , Immunohistochemistry
3.
Int J Surg Pathol ; 25(2): 173-176, 2017 Apr.
Article in English | MEDLINE | ID: mdl-27553680

ABSTRACT

Palisaded mammary-type myofibroblastoma is a rare variant of benign stromal spindle cell tumor whose histological features are well known. Nevertheless, no cytological features have been reported to date. In this article, we describe the cytological features of a case of palisaded mammary-type myofibroblastoma in which a preoperative fine needle aspirate was obtained. Smears were moderately cellular, characterized by clusters of spindle cells, disposed in a parallel fashion and immersed in myxoid background. Although the lesion is rare, it is worth distinguishing from benign and malignant spindle cell tumors.


Subject(s)
Breast Neoplasms, Male/pathology , Neoplasms, Muscle Tissue/pathology , Neoplasms, Second Primary/pathology , Adenocarcinoma/pathology , Aged , Biomarkers, Tumor/analysis , Biopsy, Fine-Needle , Colonic Neoplasms/pathology , Humans , Immunohistochemistry , Male , Papanicolaou Test
4.
Surg Endosc ; 29(6): 1586-90, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25303907

ABSTRACT

BACKGROUND: Early detection of small pancreatic cancer is important because expected survival is markedly better for tumors ≤ 2 cm. A new endoscopic ultrasound-(EUS) guided biopsy needle with side fenestration has been recently developed to enable fine-needle biopsy (FNB) under EUS guidance. The aim of this study was to evaluate the outcome of EUS-FNB using a 22-gauge ProCore needle in solid pancreatic lesions ≤ 2 cm, in terms of diagnostic accuracy and yield. METHODS: From January 2011 to December 2012, all consecutive EUS-guided tissue sampling of small pancreatic lesions (≤ 2 cm) were performed using 22-gauge ProCore needles; the data of these patients were analyzed retrospectively. RESULTS: Sixty-eight patients with a mean age of 65.7 years were included. The mean lesion size was 16.5 mm (range 5-20). None of the patients developed complications. On pathological examination, the tissue retrieved was judged adequate in 58 out of 68 cases (85.3 %) and the presence of a tissue core was recorded in 36 out of 68 cases (52.9 %). The overall sensitivity, specificity, positive predictive value, negative predictive value, and accuracy were 80, 100, 100, 40, and 82 %, respectively. CONCLUSION: Our results suggested that EUS-FNB of small pancreatic lesions using a 22-gauge ProCore needle is effective and safe, and supports our hypothesis that EUS-FNB is highly useful in establishing the nature of small pancreatic lesions.


Subject(s)
Endoscopic Ultrasound-Guided Fine Needle Aspiration/instrumentation , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Pancreas/pathology , Pancreatic Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Endoscopic Ultrasound-Guided Fine Needle Aspiration/adverse effects , Female , Humans , Male , Middle Aged , Needles , Retrospective Studies , Sensitivity and Specificity
5.
Virchows Arch ; 465(1): 49-55, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24807732

ABSTRACT

The Ki-67 labeling index has been found to bear prognostic significance in gastrointestinal neuroendocrine tumors (NETs), and it was recently incorporated in NET histological grading. Nevertheless, a reliable preoperative determination of NET grading could be useful in clinical practice. The aim of this study is to compare the results of Ki-67 labeling index, as measured on cytological samples and on surgical specimens of patients with pancreatic NETs (P-NETs). We also investigated whether concordance might be improved, using a 5 % (instead of 2 %) cutoff value for defining G2 tumors. We retrospectively identified 48 consecutive patients with 53 P-NETs, from our five institutions, and we measured Ki-67 labeling index on their cytological samples and surgical specimens. The traditional 2 % and the alternative 5 % cutoff values were used to classify G2 tumors. The concordance rate between cytological and histological grading was 46/53 (86.8 %; weighted κ statistic 0.77; 95 % confidence interval (95 % CI) 0.60-0.94). No cases of cytological G1-G2 NETs were upgraded to G3 neuroendocrine carcinoma (NEC) at histological grading. Cytology was found to be highly specific in the diagnosis of both G2 (94.1 %; 95 % CI 80.3-99.3) and G3 tumors (100.0 %; 95 % CI 92.8-100), but the sensitivity was poor for G2 NETs (66.7 %; 95 % CI 38.4-88.2) and high for the prediction of G3 NECs (100 %; 95 % CI 39.8-100.0). When the 5 % cutoff value was adopted, concordance rate was 49/53 (92.4 %; weighted κ 0.82; 95 % CI 0.64-1.00). In conclusion, Ki-67 cytological expression can distinguish well-differentiated (both G1 and G2) from poorly differentiated P-NETs, and it may be useful for their preoperative classification.


Subject(s)
Biomarkers, Tumor/metabolism , Ki-67 Antigen/metabolism , Neuroendocrine Tumors/pathology , Pancreatic Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Carcinoma, Neuroendocrine/pathology , Cell Differentiation , Female , Histocytochemistry , Humans , Male , Middle Aged , Mitotic Index , Neoplasm Grading , Prognosis , Retrospective Studies , Sensitivity and Specificity
6.
Dig Liver Dis ; 46(6): 523-6, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24704290

ABSTRACT

BACKGROUND: Endoscopic ultrasound fine needle aspiration has a central role in the diagnostic algorithm of solid pancreatic masses. Data comparing the fine needle aspiration performed with different aspiration volume and without aspiration are lacking. We compared endoscopic ultrasound fine needle aspiration performed with the 22 gauge needle with different aspiration volumes (10, 20 and 0 ml), for adequacy, diagnostic accuracy and complications. METHODS: Prospective clinical study at four referral centres. Endoscopic ultrasound fine needle aspiration was performed with a 22G needle with both volume aspiration (10 and 20 cc) and without syringe, in randomly assigned sequence. The cyto-pathologist was blinded as to which aspiration was used for each specimen. RESULTS: 100 patients met the inclusion criteria, 88 completed the study. The masses had a mean size of 32.21±11.24 mm. Sample adequacy evaluated on site was 87.5% with 20 ml aspiration vs. 76.1% with 10 ml (p=0.051), and 45.4% without aspiration (20 ml vs. 0 ml p<0.001; 10 ml vs. 0 ml p<0.001). The diagnostic accuracy was significantly better with 20 ml than with 10 ml and 0 ml (86.2% vs. 69.0% vs. 49.4% p<0.001). CONCLUSIONS: A significantly higher adequacy and accuracy were observed with the 20 ml aspiration puncture, therefore performing all passes with this volume aspiration may improve the diagnostic power of fine needle aspiration.


Subject(s)
Adenocarcinoma/pathology , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Pancreas/pathology , Pancreatic Neoplasms/pathology , Aged , Endoscopic Ultrasound-Guided Fine Needle Aspiration/instrumentation , Female , Humans , Male , Middle Aged , Prospective Studies , Sensitivity and Specificity , Single-Blind Method
7.
JOP ; 15(2): 151-64, 2014 Mar 10.
Article in English | MEDLINE | ID: mdl-24618442

ABSTRACT

CONTEXT: Hepatitis B (HBV) and hepatitis C virus (HCV) possess well-known oncogenic properties and may promote carcinogenesis in liver. However antigens and replicative sequences of HBV/HCV have been also detected in different extra-hepatic tissues, including the pancreas. Although epidemiological studies and meta-analyses have recently suggested that HBV/HCV may be also risk factors for pancreatic cancer and several researches have investigated the possible mechanisms and intra-/extra-cellular paths involved in pancreatic and hepatic carcinogenesis, to date, these complex processes remain largely unexplained. OBJECTIVES: In our paper, we aimed to propose a comprehensive and qualitative hypothetical model, describing how HBV/HCV may exert their oncogenic role. METHODS: We performed a systematic research of scientific literature, by searching MEDLINE, the Cochrane Library and EMBASE databases. The used keywords were: "chronic HBV/HCV", "pancreatic cancer", "liver carcinoma", "carcinogenesis mechanisms", "tensional integrity", "cytoskeleton", and "extracellular matrix". RESULTS: Taking advantage from available studies, we suggest an unifying hypothesis based on results and data, obtained from different areas of research. In particular we considered the well-defined model of tensional integrity and correlated it to changes induced by HBV/HCV in viscoelastic properties/stiffness of cellular/extracellular microenvironments. These events perturb the tightly-regulated feedback loop, which usually couples the intracellular-generated forces to substrate rigidity of extracellular compartments. Therefore, such a change strongly affects intracellular functions and cellular fate, by promoting a substantial deregulation of critical intracellular biochemical activities and genome expression. CONCLUSIONS: Our hypothesis might provide for the first time a reliable system, which correlates tensional integrity model with intra-/extra-cellular modifications, occurring in liver and pancreas during HBV/HCV-induced carcinogenesis. This approach might improve our understanding of pathogenetic mechanisms involved in the development of pancreatic and hepatic carcinogenesis , enhancing the possibility of their treatment. Furthermore, should the usefulness of this model be definitively confirmed, it might be also helpful to extend its field of application to other viruses-related cancers.


Subject(s)
Hepatitis B, Chronic/physiopathology , Hepatitis C, Chronic/physiopathology , Liver Neoplasms/physiopathology , Models, Biological , Pancreatic Neoplasms/physiopathology , Cytoskeleton/physiology , Extracellular Matrix/physiology , Hepacivirus/physiology , Hepatitis B virus/physiology , Hepatitis B, Chronic/complications , Hepatitis C, Chronic/complications , Humans , Liver Neoplasms/epidemiology , Pancreatic Neoplasms/epidemiology , Risk Factors
8.
PLoS One ; 9(2): e87651, 2014.
Article in English | MEDLINE | ID: mdl-24504548

ABSTRACT

The use of endoscopic ultrasonography has allowed for improved detection and pathologic analysis of fine needle aspirate material for pancreatic lesion diagnosis. The molecular analysis of KRAS has further improved the clinical sensitivity of preoperative analysis. For this reason, the use of highly analytical sensitive and specific molecular tests in the analysis of material from fine needle aspirate specimens has become of great importance. In the present study, 60 specimens from endoscopic ultrasonography fine needle aspirate were analyzed for KRAS exon 2 and exon 3 mutations, using three different techniques: Sanger sequencing, allele specific locked nucleic acid PCR and Next Generation sequencing (454 GS-Junior, Roche). Moreover, KRAS was also tested in wild-type samples, starting from DNA obtained from cytological smears after pathological evaluation. Sanger sequencing showed a clinical sensitivity for the detection of the KRAS mutation of 42.1%, allele specific locked nucleic acid of 52.8% and Next Generation of 73.7%. In two wild-type cases the re-sequencing starting from selected material allowed to detect a KRAS mutation, increasing the clinical sensitivity of next generation sequencing to 78.95%. The present study demonstrated that the performance of molecular analysis could be improved by using highly analytical sensitive techniques. The Next Generation Sequencing allowed to increase the clinical sensitivity of the test without decreasing the specificity of the analysis. Moreover we observed that it could be useful to repeat the analysis starting from selectable material, such as cytological smears to avoid false negative results.


Subject(s)
Mutation , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Proto-Oncogene Proteins/genetics , ras Proteins/genetics , Adolescent , Adult , Aged , Aged, 80 and over , Carcinoma, Pancreatic Ductal/diagnosis , Carcinoma, Pancreatic Ductal/genetics , Carcinoma, Pancreatic Ductal/pathology , DNA Mutational Analysis/methods , DNA Mutational Analysis/standards , Endoscopic Ultrasound-Guided Fine Needle Aspiration , Exons , Female , High-Throughput Nucleotide Sequencing , Humans , Male , Middle Aged , Pancreatic Neoplasms/diagnosis , Proto-Oncogene Proteins p21(ras) , Reproducibility of Results , Young Adult
9.
Dig Liver Dis ; 46(1): 45-50, 2014 Jan.
Article in English | MEDLINE | ID: mdl-23916241

ABSTRACT

BACKGROUND: Cytologic diagnosis by endoscopic ultrasound-guided fine needle aspiration is associated with low sensitivity and adequacy. A newly designed endoscopic ultrasound-guided fine needle biopsy device, endowed with a side fenestration, is now available. AIMS: We carried out a study with the aim of evaluating the feasibility, safety, and diagnostic yield of the 22-gauge needle with side fenestration for endoscopic ultrasound fine needle aspiration and biopsy of pancreatic cystic lesions. METHODS: 58 patients with 60 pancreatic cystic lesions consecutively referred for endoscopic ultrasound guided-fine needle aspiration were enrolled in a prospective, dual centre study, and underwent fine needle aspiration and biopsy with the 22-gauge needle with side fenestration. RESULTS: Fine needle aspiration and biopsy was technically feasible in all cases. In 39/60 (65%) pancreatic cystic lesions, the specimens were adequate for cyto-histologic assessment. In lesions with solid components, and in malignant lesions, adequacy was 94.4% (p = 0.0149) and 100% (p = 0.0069), respectively. Samples were adequate for histologic evaluation in 18/39 (46.1%) cases. There were only 2 (3.3%) mild complications. CONCLUSIONS: Fine needle aspiration and biopsy with the 22-gauge needle with side fenestration is feasible, and superior to conventional endoscopic ultrasound-guided fine needle aspiration cytology from cystic fluid, particularly in pancreatic cystic lesions with solid component or malignancy, with a higher diagnostic yield and with no increase in complication rate.


Subject(s)
Carcinoma, Pancreatic Ductal/pathology , Cystadenocarcinoma, Mucinous/pathology , Cystadenoma, Serous/pathology , Endoscopic Ultrasound-Guided Fine Needle Aspiration/methods , Neuroendocrine Tumors/pathology , Pancreatic Cyst/pathology , Pancreatic Neoplasms/pathology , Pancreatic Pseudocyst/pathology , Aged , Cohort Studies , Cytodiagnosis , Endoscopic Ultrasound-Guided Fine Needle Aspiration/instrumentation , Feasibility Studies , Female , Humans , Male , Middle Aged , Needles
10.
Dig Liver Dis ; 45(11): 957-60, 2013 Nov.
Article in English | MEDLINE | ID: mdl-23876743

ABSTRACT

BACKGROUND: A solid pseudopapillary tumour of the pancreas (SPTP) is a rare neoplasm. AIM: We herein present five cases of SPTP diagnosed using endoscopic ultrasound (EUS) guided fine-needle biopsy (FNB) using a needle with side fenestration (ProCore-needle). METHODS: From January 2011 to June 2012 in five patients with SPTP tissue acquisition was carried out with a 19-gauge (4 patients) or a 22-gauge (one patient) needle. RESULTS: The mean age of the patients was 30.8 years, the mean lesion size was 49mm and the most common location was the tail of the pancreas (3 cases). When the samples were evaluated macroscopically, small core fragments were observed in all cases. A preoperative diagnosis of SPTP was made in all patients on the basis of the histocytological and characteristic immunophenotypic patterns and was confirmed at final surgical histology. CONCLUSIONS: In our experience, EUS-FNB is an effective and secure method for a preoperative diagnosis of SPTP.


Subject(s)
Biopsy, Fine-Needle/methods , Carcinoma, Papillary/diagnosis , Endosonography/methods , Image-Guided Biopsy/methods , Pancreatectomy , Pancreatic Neoplasms/diagnosis , Adolescent , Adult , Carcinoma, Papillary/surgery , Diagnosis, Differential , Female , Follow-Up Studies , Humans , Male , Middle Aged , Pancreas/diagnostic imaging , Pancreas/pathology , Pancreas/surgery , Pancreatic Neoplasms/surgery , Preoperative Period , Reproducibility of Results , Retrospective Studies , Young Adult
11.
Int J Surg Pathol ; 21(6): 546-52, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23426962

ABSTRACT

KRAS is one of the most common genes mutated in pancreatic adenocarcinoma. Multiple KRAS mutations may be detected within the same pancreatic adenocarcinoma, but it is usually unclear whether the different mutations represent biologically irrelevant molecular events or whether they indicate the coexistence of distinct sizable neoplastic clones within a given tumor. We identified a case of pancreatic adenocarcinoma with 5 different mutations in the KRAS gene and have been able to characterize the allelic distribution of the KRAS mutations and the size of the neoplastic clones using allele-specific locked nucleic acid polymerase chain reaction and next-generation sequencing (454 GS-Junior). The results indicate that the tumor is composed of 5 distinct cell populations: one is KRAS G12V mutated (~38% of neoplastic cells), the second is KRAS G12V in one allele and KRAS G12D in the other (~32%), the third is KRAS G12V in one allele and KRAS G12R in the other (~24%), and the fourth is KRAS G12V in one allele and KRAS G12C in the other (~6%). The fifth clone, representing a minority of neoplastic cells, has a KRAS Q61H mutation in addition to one of the above alterations. Microsatellite analysis identified mutation of the NR21 marker out of the 13 tested, indicating that the tumor has a defect in maintaining DNA integrity different from loss of conventional DNA mismatch repair. These results are consistent with the successive selection of divergent populations of tumor cells and underscore the relevance of nucleotide instability in pancreatic adenocarcinoma.


Subject(s)
Adenocarcinoma/genetics , Mutation , Pancreatic Neoplasms/genetics , Proto-Oncogene Proteins/genetics , ras Proteins/genetics , Adenocarcinoma/pathology , Aged, 80 and over , Clone Cells , DNA Mutational Analysis , Female , Humans , Pancreatic Neoplasms/pathology , Proto-Oncogene Proteins p21(ras)
12.
Future Oncol ; 8(11): 1495-500, 2012 Nov.
Article in English | MEDLINE | ID: mdl-23148622

ABSTRACT

Relatively few cases of splenic metastases have been reported in the literature. Metastases to the spleen generally occur in the context of multivisceral involvement during the late stage of disease, while isolated splenic metastases are far less frequent. The primary cancer types commonly leading to splenic metastases are skin melanoma and gynecologic, colorectal and gastric cancers. Breast cancer is considered a rare source of splenic metastases, with few cases being reported in the literature. As a contribution to the literature, we report here on a case of splenic metastasis in a patient with breast cancer treated at the Department of Medical Oncology at our institution (Bellaria-Maggiore Hospital, Azienda USL of Bologna, Italy).


Subject(s)
Breast Neoplasms/pathology , Splenic Neoplasms/secondary , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Biopsy , Breast Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Female , Humans , Middle Aged , Splenic Neoplasms/diagnosis , Splenic Neoplasms/drug therapy , Tomography, X-Ray Computed
13.
Case Rep Oncol Med ; 2012: 619428, 2012.
Article in English | MEDLINE | ID: mdl-23091757

ABSTRACT

We report the case of a woman who, during oncological followup for bronchial carcinoid (diagnosed in 2005), papillary thyroid carcinoma, and bilateral parathyroid adenoma (simultaneously diagnosed in 2007), performed a pancreatic endoscopic ultrasonography with fine needle agobiopsy (EUS-FNA) for a positron emission tomography (PET) suspicion of pancreatic and hepatic lesions; during the procedure, the pancreatic and liver lesions were confirmed, and a peripancreatic lymph node involvement was found, allowing a complete pTNM staging during the same procedure.

14.
Pancreatology ; 12(3): 203-5, 2012.
Article in English | MEDLINE | ID: mdl-22687373

ABSTRACT

BACKGROUND: Pancreatic mucinous cystic lesions might develop malignancy if untreated, or could harbor malignancy at the time of the diagnosis. Many reports stated that cyst fluid carcinoembryonic antigen is an accurate diagnostic marker of pancreatic mucinous cysts. METHODS: A man with a incidental pancretic cystic lesion of 35 mm in diameter was admitted to our Department. CT and EUS did not reveal solid components, main duct was not dilated and cyst fluid CEA was very high (1445 ng/ml). RESULTS: The patient underwent a pancreatoduodenectomy and the surgical specimen showed a pseudocyst with columnar mucinous epithelium, consistent with low-grade PanIN. CONCLUSIONS: Is it possible that the mucinous epithelium of panIN was responsible for the unexpectedly high CEA value? Clinicians should be aware of the usefulness of the CEA level in cystic fluid but even a very high CEA value should not be considered by itself to be evidence of a mucinous lesion.


Subject(s)
Carcinoembryonic Antigen/analysis , Cyst Fluid/chemistry , Neoplasms, Cystic, Mucinous, and Serous/pathology , Pancreatic Cyst/pathology , Pancreatic Pseudocyst/pathology , Endosonography , Humans , Male , Middle Aged , Neoplasms, Cystic, Mucinous, and Serous/diagnostic imaging , Pancreatic Cyst/diagnosis , Pancreatic Cyst/diagnostic imaging , Pancreatic Cyst/surgery , Pancreatic Neoplasms/diagnosis , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/pathology , Pancreatic Pseudocyst/diagnosis , Pancreatic Pseudocyst/surgery
15.
Int J Colorectal Dis ; 27(5): 647-56, 2012 May.
Article in English | MEDLINE | ID: mdl-22108904

ABSTRACT

PURPOSE: Stratifying patients defective in mismatch repair (dMMR) with high microsatellite instability (MSI-H) in colorectal cancer (CRC) is of increasing relevance and may provide a more tailored approach to CRC adjuvant therapy. Here, we describe the discovery of a new MSI marker for colorectal cancer located in the 3'-untranslated region (3'UTR, T20 mononucleotide repeat) of the metallothionein 1X gene (MT1XT20). METHODS: We studied 340 consecutive CRCs using three multiplexed polymerase chain reactions amplifying BAT25, BAT26, TGFBR2, MybT22, BAT40, MT1XT20, NR21, NR24, CAT25, D2S123, D5S346, D17S250, D18S58, CSF1PO, D7S820, and D18S51. Fragments length was evaluated by automated capillary electrophoresis. RESULTS: Based on the NCI/ICG-HNPCC criteria for MSI classification, 40 CRCs were found to be MSI-high (11.8%), 46 (13.5%) CRCs were MSI-low, and 254 CRCs (74.7%) were stable (MSS). MT1XT20 showed very high sensitivity (97.3%) comparable to BAT26 (97.5%) and CAT25 (97.1%) and the best specificity (100%) as well as MybT22 and CAT25. Indeed, MT1XT20 instability was detected in 36 out of 37 cases (97.3%) of MSI-high colorectal cancers, whereas no MT1XT20 alterations were observed in 254 MSS or in 46 MSI-low cases. On the contrary, BAT40 was found to be unstable in 8/46 MSI-low cases, BAT25 in 6/46, BAT26 4/46, NR21 1/46, and NR24 in 1/45. CONCLUSIONS: Our results suggest that MT1XT20 represents a sensitive and specific marker for MSI testing and could be included in a complete set of MSI markers for the confident identification of familial or sporadic dMMR patients in CRCs.


Subject(s)
Biomarkers, Tumor/genetics , Colorectal Neoplasms/genetics , Metallothionein/genetics , Microsatellite Instability , Tandem Repeat Sequences/genetics , 3' Untranslated Regions , Adult , Aged , Aged, 80 and over , DNA Mismatch Repair , Female , Genetic Markers , Humans , Male , Polymerase Chain Reaction , Sensitivity and Specificity
16.
Dig Liver Dis ; 43(8): 647-52, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21592873

ABSTRACT

BACKGROUND: The difference in the diagnostic accuracy of 22- versus 25-gauge needles in EUS-FNA is not clear. AIMS: To compare the rates of technical success, diagnostic accuracy and complications of EUS-FNA performed with 22-gauge and 25-gauge needles on the same solid pancreatic mass. METHODS: All patients with solid pancreatic masses evaluated from September 2007 to December 2008 were enrolled and underwent EUS-FNA with both 22- and 25-gauge needles with randomisation of needle sequence. The accuracy of the EUS-FNA was determined by comparing the cytological results with the final surgical pathological diagnoses or with the results of a clinical follow-up. A cytological score with different qualitative parameters was created, and a comparison between these parameters was carried out for each needle. RESULTS: Fifty patients with 50 pancreatic masses were recruited. Technical success was 100% and no complications occurred. Diagnostic accuracy was 94% and 86% for the 25- and 22-gauge needles, respectively. Analysis of the cytological score showed a tendency towards the 25-gauge needle, although the difference was not statistically significant. CONCLUSIONS: EUS-FNA performed with 22- or 25-gauge needles had the same diagnostic accuracy. Our study results confirm a significant trend towards a better cytological diagnosis for the 25-gauge needle.


Subject(s)
Biopsy, Fine-Needle/instrumentation , Pancreatic Neoplasms/pathology , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Predictive Value of Tests , Prospective Studies , Reproducibility of Results , Ultrasonography, Interventional
17.
Hum Pathol ; 34(12): 1331-6, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14691920

ABSTRACT

Human cytomegalovirus (HCMV) infection is usually reported in immunocompromised patients. This study reports 11 cases of HCMV infection of the gastrointestinal (GI) tract diagnosed in apparently immunocompetent hosts. The median age of the patients studied was 76 years, and the major presenting symptoms were diarrhea, epigastric pain, and abdominal discomfort. The large intestine was involved in 6 cases, the stomach in 4 cases, and the lower esophagus in 1 case. Endoscopy revealed ulcers or hypertrophic folds in the GI tract and single ulcers or erosions in the colon and rectum. Light microscopy showed chronic inflammatory infiltrate in the lamina propria in all cases. The diagnosis of HCMV infection was based on the histological and immunohistochemical identification of HCMV inclusion bodies in different cell types, including epithelial, endothelial, stromal, and smooth muscle cells. Both "classical" inclusions, characterized by an "owl's eye" appearance, and atypical inclusions were found. For all patients, no apparent causes of immunodeficiency were detected at the time of diagnosis of HCMV infection. At follow-up, however, 4 patients were found to harbor a malignant tumor (ie, pancreas, lung, Vater's papilla, and extrahepatic bile duct) at an interval of 2 to 5 months after the diagnosis of HCMV infection. Especially in elderly patients, HCMV infection of the GI tract might be an early clue to the presence of immunologic defects induced by an underlying neoplasia.


Subject(s)
Cytomegalovirus Infections/immunology , Cytomegalovirus Infections/pathology , Gastrointestinal Tract/pathology , Gastrointestinal Tract/virology , Immunocompetence , Aged , Aged, 80 and over , Cytomegalovirus/isolation & purification , Cytomegalovirus Infections/complications , Female , Follow-Up Studies , Humans , Immunohistochemistry , Inclusion Bodies, Viral/pathology , Male , Middle Aged , Neoplasms/complications
18.
Hum Pathol ; 33(12): 1237-40, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12514794

ABSTRACT

Malignant granular cell tumors (MGCTs) are rare neoplasms of uncertain histogenesis. We report a case of MGCT involving a peripheral nerve with peritoneal and omental dissemination in which cytogenetic findings are available. Our results show that MGCTs share some cytogenetic abnormalities with malignant peripheral nerve sheath tumors (MPNSTs), supporting the hypothesis that they may represent histogenetically related lesions.


Subject(s)
Chromosome Aberrations , Granular Cell Tumor/genetics , Granular Cell Tumor/therapy , Peripheral Nervous System Neoplasms/genetics , Peripheral Nervous System Neoplasms/therapy , Adult , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Granular Cell Tumor/pathology , Humans , Karyotyping , Magnetic Resonance Imaging , Male , Neoplasm Metastasis , Omentum/pathology , Peripheral Nervous System Neoplasms/pathology , Peritoneum/pathology , Surgical Procedures, Operative
SELECTION OF CITATIONS
SEARCH DETAIL
...